DRHP Status : Not Filed
2120
All documents are provided for informational purposes and are subject to regulatory disclosures.
| P&L Statement | 2024 |
|---|---|
| Revenue | 70.5 |
| Cost of Material Consumed | 48.2 |
| Change in Inventory | -7.2 |
| Gross Margins | 41.84 |
| Employee Benefit Expenses | 1.1 |
| Other Expenses | 1.7 |
| EBITDA | 26.7 |
| OPM | 37.87 |
| Other Income | 0.22 |
| Finance Cost | 0.14 |
| D&A | 0.02 |
| EBIT | 26.68 |
| EBIT Margins | 37.84 |
| PBT | 26.7 |
| PBT Margins | 37.87 |
| Tax | 6.7 |
| PAT | 20 |
| NPM | 28.37 |
| EPS | 42.11 |
Financial Ratios |
2024 |
|---|---|
| Operating Profit Margin | 37.87 |
| Net Profit Margin | 28.37 |
| Earning Per Share (Diluted) | 42.11 |
| Assets | 2024 |
|---|---|
| Fixed Assets | 0.47 |
| CWIP | 0 |
| Investments | 0 |
| Trade Receivables | 71.5 |
| Inventory | 7.3 |
| Other Assets | 26.73 |
| Total Assets | 106 |
| Liabilities | 2024 |
|---|---|
| Share Capital | 4.75 |
| FV | 10 |
| Reserves | 40 |
| Borrowings | 14 |
| Trade Payables | 27 |
| Other Liabilities | 20.25 |
| Total Liabilities | 106 |
Maverick Simulation Solutions Limited, based in New Delhi and established as a leader in medical simulation, designs, manufactures, and supplies high-fidelity, "Made-in-India" simulators for healthcare training. Founded by Anuj Chahal in 2006, the company pivoted to medtech in 2019, providing advanced, AI/VR-enabled tools for medical institutions to enhance skills and patient safety
The following table shows a 10-point analysis of Maverick Simulation Solutions Limited. We will discuss each point in detail after this table.
| Parameter | Key Numbers | Insights |
|---|---|---|
| Business Overview | Incorporated 2019 (medical domain) | A simulation technology company focused on healthcare training solutions. |
| Industry | MedTech · Simulation Technology | Operates in the medical education and training infrastructure. |
| Core Products | Medical simulators · training systems | Offers task trainers, high-fidelity simulators, and virtual labs. |
| Client Base | 100+ institutions | Includes medical colleges, hospitals, and institutions. |
| Revenue | ₹136.3 Cr (FY25) | Strong growth from ₹14.2 Cr in FY24. |
| Profitability | ₹47.8 Cr PAT (FY25) | Significant improvement in margins. |
| EBITDA | Strong margin expansion | Driven by scale and product mix. |
| Debt Position | Low leverage (0.24x) | Comfortable balance sheet. |
| Business Model | Product + turnkey solutions | Revenue from equipment and simulation lab setups. |
| Outlook | High-growth medtech segment | Driven by digital healthcare education demand. |
Company Overview
(i) Maverick Simulation Solutions Limited is a medical simulation technology company that develops advanced training systems for healthcare education and clinical skill development.
(ii) The company offers a wide range of simulation products, including task trainers, full-body patient simulators, and virtual anatomy systems, used for training medical students and professionals.
(iii) It provides end-to-end solutions such as simulation labs, digital anatomy platforms, and turnkey training infrastructure, enabling institutions to adopt modern learning methods.
(iv) Maverick serves 100+ institutions, including AIIMS, IITs, and other medical colleges, reflecting strong institutional adoption.
(v) The company is focused on innovation, with a planned ₹50 crore investment in R&D to integrate AI, AR, and VR into medical training solutions.
Here are some highlights of the financial performance of Maverick Simulation Solutions Limited over the past few years.
• Revenue from operations stood at ₹136.30 crore
• Profit before tax stood at ₹61.30 crore
• Profit after tax reported at ₹47.82 crore
• Net profit margin expanded to 35%
• Revenue from operations stood at ₹14.22 crore
• Profit before tax stood at ₹1.26 crore
• Profit after tax reported at ₹0.94 crore
• Margins remained modest due to the early growth stage
• Revenue base was early-stage and limited scale
• Profitability remained low due to the expansion phase
• Investments focused on product development and scaling
• Business was in the initial commercialisation phase
Quick Summary
Maverick Simulation Solutions Limited is a high-growth medtech company operating in the healthcare simulation space. The company has demonstrated a sharp financial turnaround in FY25, with strong revenue growth and margin expansion. With increasing adoption of simulation-based learning and continued investment in R&D, the company holds strong long-term growth potential, though working capital and technology risks remain key factors.
Click Here to visit the official website of Maverick Simulation Solutions Limited.
The following are the active promoters/leadership associated with the company:
| Name | Designation | LinkedIn Profile |
|---|---|---|
| Anuj Chahal | Founder & CEO | View Profile |
| Dr. Sunil Tomar | Director | - |
| Name | Holding |
|---|---|
| Promoters | 82.74% |
| Other | 17.26% |
| Name | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Anuj Chahal | Founder & CEO | 20+ | ![]() |
| Dr. Sunil Tomar | Director | 20+ | ![]() |
Coming soon...
Maverick Simulation Solutions Limited unlisted shares are equity shares of the company that are not listed on NSE or BSE and are traded privately.
Yes, Maverick Simulation Solutions Limited unlisted shares can be purchased through private market platforms, subject to availability.
Yes, a demat account is required to hold Maverick Simulation Solutions Limited unlisted shares.
The company operates in a high-growth medtech segment with great financial improvement, but like all unlisted investments, it carries liquidity and execution risks.
Yes, Maverick Simulation Solutions Limited unlisted shares can be sold in the secondary market depending on demand and availability.
Yes, as per SEBI regulations, pre-IPO investors are subject to a six-month lock-in period after listing.
If held for more than two years, gains are taxed at 20% with indexation; otherwise, taxed as per the income slab.